FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995936542> ?p ?o ?g. }

• W1995936542 endingPage "359" @default.
• W1995936542 startingPage "351" @default.
• W1995936542 abstract "The purpose of this study is to compare the long-term effects of an angiotensin II receptor blocker (ARB) and a long-acting calcium channel blocker (CCB) on left ventricular geometry, hypertensive renal injury and a circulating marker of collagen synthesis in hypertensive patients. Patients with essential hypertension (24 men and 19 women; age, 37–79 years) were treated with a long-acting CCB, amlodipine (AML; 2.5–7.5 mg once daily) for 6 months. Then, AML was switched to an ARB, candesartan (CS; 4–12 mg once daily), in 22 patients (CS group), while AML was continued in the remaining 21 patients for another 6 months (AML group). At the end of each treatment period, ambulatory blood pressure monitoring (ABPM), echocardiography and sampling of blood and urine were performed. The average office blood pressure during the latter period was comparably controlled in the AML and the CS groups (AML: 130±8/87±7 mmHg; CS: 133±11/88±7 mmHg), while the average systolic blood pressure of 24-h ABPM was significantly lower in the AML than in the CS group (127±9 vs. 133 ±14 mmHg, p<0.05). Consequently, the left ventricular mass index was significantly decreased in the AML group (102±18 to 92±12 g/m2, p<0.05), while the change was insignificant in the CS group (103±25 to 98±21 g/m2). On the other hand, plasma procollagen I C-terminal peptide (PICP), a marker of collagen synthesis, was lowered by CS (86±21 to 70±21 ng/ml, p<0.01), but was not significantly affected by AML (80±127 to 74±91 ng/ml). CS reduced urinary albumin excretion (57±123 to 26±33 mg/g creatinine, p<0.05), but AML did not bring about significant changes (85±27 to 73±19 mg/g creatinine). The results suggested that long-acting CCBs are effective in improving left ventricular hypertrophy by controlling 24-h blood pressure, while ARBs possess protective effects against cardiovascular fibrosis and renal injury beyond their antihypertensive effects." @default.
• W1995936542 created "2016-06-24" @default.
• W1995936542 creator A5021763876 @default.
• W1995936542 creator A5031047467 @default.
• W1995936542 creator A5037149546 @default.
• W1995936542 creator A5039257959 @default.
• W1995936542 creator A5053339100 @default.
• W1995936542 creator A5053746933 @default.
• W1995936542 creator A5057681787 @default.
• W1995936542 creator A5061549158 @default.
• W1995936542 creator A5083374145 @default.
• W1995936542 creator A5084260587 @default.
• W1995936542 date "2005-01-01" @default.
• W1995936542 modified "2023-10-12" @default.
• W1995936542 title "Protective Effects of an Angiotensin II Receptor Blocker and a Long-Acting Calcium Channel Blocker against Cardiovascular Organ Injuries in Hypertensive Patients" @default.
• W1995936542 cites W1886118117 @default.
• W1995936542 cites W1964833810 @default.
• W1995936542 cites W1969748795 @default.
• W1995936542 cites W1970395952 @default.
• W1995936542 cites W1973322174 @default.
• W1995936542 cites W1975196657 @default.
• W1995936542 cites W1979030376 @default.
• W1995936542 cites W1994915655 @default.
• W1995936542 cites W1997338078 @default.
• W1995936542 cites W1998998382 @default.
• W1995936542 cites W2018718905 @default.
• W1995936542 cites W2021011733 @default.
• W1995936542 cites W2024105159 @default.
• W1995936542 cites W2034022081 @default.
• W1995936542 cites W2042293234 @default.
• W1995936542 cites W2062460487 @default.
• W1995936542 cites W2075454034 @default.
• W1995936542 cites W2075522000 @default.
• W1995936542 cites W2084300519 @default.
• W1995936542 cites W2089082626 @default.
• W1995936542 cites W2093009820 @default.
• W1995936542 cites W2100082183 @default.
• W1995936542 cites W2106761290 @default.
• W1995936542 cites W2114634962 @default.
• W1995936542 cites W2117140855 @default.
• W1995936542 cites W2119620107 @default.
• W1995936542 cites W2123159073 @default.
• W1995936542 cites W2124405902 @default.
• W1995936542 cites W2132479352 @default.
• W1995936542 cites W2133217116 @default.
• W1995936542 cites W2134264965 @default.
• W1995936542 cites W2137408480 @default.
• W1995936542 cites W2139805666 @default.
• W1995936542 cites W2153034914 @default.
• W1995936542 cites W2154093137 @default.
• W1995936542 cites W2172032309 @default.
• W1995936542 cites W2322154929 @default.
• W1995936542 cites W4237002514 @default.
• W1995936542 cites W4237823265 @default.
• W1995936542 cites W4249227027 @default.
• W1995936542 doi "https://doi.org/10.1291/hypres.28.351" @default.
• W1995936542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16138566" @default.
• W1995936542 hasPublicationYear "2005" @default.
• W1995936542 type Work @default.
• W1995936542 sameAs 1995936542 @default.
• W1995936542 citedByCount "24" @default.
• W1995936542 countsByYear W19959365422012 @default.
• W1995936542 countsByYear W19959365422015 @default.
• W1995936542 countsByYear W19959365422016 @default.
• W1995936542 countsByYear W19959365422019 @default.
• W1995936542 countsByYear W19959365422021 @default.
• W1995936542 crossrefType "journal-article" @default.
• W1995936542 hasAuthorship W1995936542A5021763876 @default.
• W1995936542 hasAuthorship W1995936542A5031047467 @default.
• W1995936542 hasAuthorship W1995936542A5037149546 @default.
• W1995936542 hasAuthorship W1995936542A5039257959 @default.
• W1995936542 hasAuthorship W1995936542A5053339100 @default.
• W1995936542 hasAuthorship W1995936542A5053746933 @default.
• W1995936542 hasAuthorship W1995936542A5057681787 @default.
• W1995936542 hasAuthorship W1995936542A5061549158 @default.
• W1995936542 hasAuthorship W1995936542A5083374145 @default.
• W1995936542 hasAuthorship W1995936542A5084260587 @default.
• W1995936542 hasBestOaLocation W19959365421 @default.
• W1995936542 hasConcept C104849204 @default.
• W1995936542 hasConcept C126322002 @default.
• W1995936542 hasConcept C126894567 @default.
• W1995936542 hasConcept C149323552 @default.
• W1995936542 hasConcept C164705383 @default.
• W1995936542 hasConcept C2776002628 @default.
• W1995936542 hasConcept C2779646130 @default.
• W1995936542 hasConcept C2780036600 @default.
• W1995936542 hasConcept C2780356492 @default.
• W1995936542 hasConcept C2908929049 @default.
• W1995936542 hasConcept C71924100 @default.
• W1995936542 hasConcept C84393581 @default.
• W1995936542 hasConceptScore W1995936542C104849204 @default.
• W1995936542 hasConceptScore W1995936542C126322002 @default.
• W1995936542 hasConceptScore W1995936542C126894567 @default.
• W1995936542 hasConceptScore W1995936542C149323552 @default.
• W1995936542 hasConceptScore W1995936542C164705383 @default.
• W1995936542 hasConceptScore W1995936542C2776002628 @default.
• W1995936542 hasConceptScore W1995936542C2779646130 @default.
• W1995936542 hasConceptScore W1995936542C2780036600 @default.

• next